Loading organizations...

Scribe is an AI based Sales Development Representative that you can…
Scribe has raised $55.0M across 3 funding rounds.
Key people at Scribe.
Scribe was founded in 2016 by Rutika Muchhala (Founder) and Sachin Bhat (Founder).
Scribe has raised $55.0M in total across 3 funding rounds.
Scribe is an AI-Powered Sales Assistant for your inside sales team, that you can hire in <10 minutes.
Scribe magically finds the best prospects, writes highly personalized emails, handles objections and schedules demos with pre-qualified leads. To put it into perspective, our customers have been able to get 3X the number of qualified meetings for 50% of the cost, and your SDRs can now focus on only the warmest leads.
Scribe is backed by Y Combinator and other elite Silicon Valley investors and is fundamentally transforming sales.
Scribe was founded in 2016 by Rutika Muchhala (Founder) and Sachin Bhat (Founder).
Scribe has raised $55.0M in total across 3 funding rounds.
Scribe's investors include Amplify Partners, Andreessen Horowitz, FirstMark Capital, First Round Capital, Okta Ventures, Redpoint Ventures, Spark Capital, Uncork Capital, Matt Garratt, Moshe Lifschitz, 8VC, Bain Capital Ventures.
Key people at Scribe.
Scribe is an AI-powered Sales Development Representative (SDR) platform designed to automate and enhance inside sales processes. It helps sales teams by finding the best prospects, generating highly personalized outreach emails, handling objections, and scheduling demos with pre-qualified leads. Scribe’s AI enables sales development teams to triple their number of qualified meetings at half the cost, allowing human SDRs to focus on warmer leads and higher-value interactions. The product primarily serves B2B sales teams, especially inside sales and SDR groups, aiming to improve efficiency, pipeline generation, and conversion rates through AI-driven automation and personalization[2][3].
Scribe was founded before or around 2017 and participated in Y Combinator’s Winter 2017 batch, indicating its Silicon Valley startup roots and early backing by elite investors. The founding team leveraged AI to address the labor-intensive and repetitive tasks in sales development, such as prospecting and email outreach. Early traction came from demonstrating significant ROI improvements for sales teams, including increased qualified meetings and reduced costs, which helped establish Scribe as a transformative tool in sales automation[2].
Scribe rides the wave of AI adoption in sales, a sector increasingly reliant on automation to handle large volumes of inbound and outbound prospecting. The timing is critical as sales teams face pressure to scale outreach while maintaining personalization and relevance. Market forces such as the rise of AI, CRM integration, and the need for data-driven sales insights favor Scribe’s approach. By automating routine SDR tasks and enabling smarter engagement, Scribe influences the broader ecosystem by setting new standards for AI-assisted sales productivity and reshaping how inside sales teams operate[2][3][4].
Looking ahead, Scribe is well-positioned to expand its AI capabilities, potentially incorporating more advanced natural language understanding and predictive analytics to further refine lead qualification and engagement strategies. Trends such as increased AI adoption in B2B sales, multilingual support, and deeper CRM integrations will shape its evolution. As AI becomes more embedded in sales workflows, Scribe’s influence could grow from a tool for SDRs to a comprehensive sales acceleration platform, driving higher efficiency and effectiveness across the sales funnel.
In summary, Scribe exemplifies the transformation of sales development through AI, enabling teams to scale personalized outreach efficiently while focusing human effort where it matters most. This aligns with the broader shift towards AI-augmented workforces in tech-driven industries[2][3][4].
Scribe has raised $55.0M across 3 funding rounds. Most recently, it raised $25.0M Series B in February 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2024 | $25.0M Series B | Amplify Partners, Andreessen Horowitz, FirstMark Capital, First Round Capital, Okta Ventures, Redpoint Ventures, Spark Capital, Uncork Capital, Matt Garratt, Moshe Lifschitz | |
| Oct 1, 2021 | $22.0M Series A | 8VC, Amplify Partners, Bain Capital Ventures, Bowery Capital, Harpoon, Hoxton Ventures, Lightspeed Venture Partners, Pareto Holdings, Picus Capital, Spark Capital, Y Combinator, Akshay Bhargava, Catherine Lu, Gokul Rajaram, Jeff Seibert, Ron Pragides, Samvit Ramadurgam, Sohail Prasad, Wayne Chang | |
| Dec 1, 2020 | $8.0M Seed | 8VC, Allison Pickens Ventures, formerly The New Normal Fund, Amplify Partners, Bain Capital Ventures, Bowery Capital, Harpoon, Hoxton Ventures, Lightspeed Venture Partners, Pareto Holdings, Picus Capital, Spark Capital, Todd and Rahul's Angel Fund, Y Combinator, Akshay Bhargava, Catherine Lu, Gokul Rajaram, Jeff Seibert, Ron Pragides, Samvit Ramadurgam, Sohail Prasad, Wayne Chang |